Remove 2019 Remove Clinical Trials Remove Events Remove History
article thumbnail

Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators

NORML

The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials. The Court’s order permits petitioners to return to the Court of Appeals “in the event” that DEA engages in “significant delays” in the future.

DEA 103
article thumbnail

Cannabis laws in Japan: Is weed legal?

The Cannigma

However, the country has a history of cannabis art dating back millenia , and scholars believe that the plant was used for centuries as a textile and for use in traditional Shinto ceremonies. But in modern times? That could potentially change in the near future, however. Amphetamines are the most popular drug of choice in Japan.).

Law 137
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Applied DNA Subsidiary LineaRx Receives Repeat Orders for LinearDNA, Adds Federally Funded Cancer Research Laboratory as CRO Customer

Cannabis Law Report

Although a limited number of CGTs are currently on the market, FDA officials predicted in 2019 that the agency will receive more than 200 investigational new drug applications per year for cell and gene therapies and that by 2025, it expects to have accelerated to 10 to 20 cell and gene therapy approvals per year 1. January 15, 2019.

article thumbnail

And Here We Go Again! NASDAQ Article: Forget Cannabis: Psychedelic Medicine Is the Better Investing Opportunity

Cannabis Law Report

This renewed interest in psychedelics is being sparked by a pair of seemingly unrelated events. In March 2019, J&J’s hard work paid off when the FDA approved Spravato for treatment-resistant depression. Hundreds of other U.S. cities are reportedly considering similar measures at the moment.

article thumbnail

The John Hopkins Center for Psychedelic and Consciousness Research Publishes Inaugural Edition Of Newsletter

Cannabis Law Report

Upcoming Events. November 21, 2019. Dr. Griffiths and Dr. Johnson will be speaking at Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks conference in Washington DC. December 3, 2019. December 4, 2019. December 6, 2019. December 8-11, 2019.

Therapy 59
article thumbnail

Dalrada Corporation Expands Presence in Top Three Growth Industries: Clean Energy, Healthcare, Technology (IT)

Cannabis Law Report

This calendar year marks a synchronous period in Dalrada’s history when its impactful innovations and solutions of all its subsidiaries expanded market presence into the top three largest growing industries : clean energy, healthcare, and technology. billion in 2019 Q3. In its history, IHG has graduated nearly 8,000 students.

article thumbnail

Delic to Acquire Ketamine Wellness Centers Inc, Becoming Largest Psychedelic Wellness Chain in United States

Cannabis Law Report

Delic expects to open 15 additional clinics across the country over the coming 18 months, further expanding access to millions who can benefit from psychedelic treatment for a variety of mental health conditions. Established history of providing ketamine infusion services: The management team at KWC has been in ?business